Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Marsh & McLennan stock price target raised to $221 on growth optimism

EditorBrando Bricchi
Published 04/18/2024, 01:14 PM

On Thursday, Evercore ISI adjusted its outlook for Marsh & McLennan (NYSE:MMC), a global professional services firm, by increasing its price target from $218.00 to $221.00. The firm maintained its Outperform rating on the stock. The revision comes after considering the company's financial performance and expectations for the future.

The company's recent earnings report showed robust underlying revenue growth, which, according to Evercore ISI, has more significance than a slight margin miss. This strong performance is anticipated to continue into the second half of 2024, with expectations for greater margin expansion. Consequently, Evercore ISI has increased its earnings per share (EPS) estimates by 1% to reflect a higher organic growth trajectory and a modest increase in fiduciary income, despite foreign exchange headwinds.

Evercore ISI acknowledged the slowdown in the Marsh Global Pricing index, which could be perceived negatively for the commercial insurance industry. However, Marsh & McLennan's efforts to minimize its impact on organic growth were noted, citing strong exposure growth and market share gains, including better retention rates, as key drivers of future growth. These factors are expected to continue to contribute positively.

The firm also referenced Travelers Companies Inc.'s (NYSE:TRV) first-quarter results, which suggest that casualty rates might accelerate. Yet, the stable casualty rate increase of +3% was unexpected given ongoing social inflation and reserve challenges. Evercore ISI has incorporated a slightly improved organic growth forecast into its new estimates, arguing that the sustainability of stronger-than-expected exposure growth, combined with market share gains and an overall increase in insurance purchasing, could counterbalance any pricing deceleration.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lastly, Evercore ISI speculated that Marsh & McLennan's investments in organic growth initiatives could be yielding results, as evidenced by higher market share gains. The increased price target to $221 reflects the firm's updated higher earnings estimates.

InvestingPro Insights

As Marsh & McLennan (NYSE:MMC) continues to demonstrate its operational prowess, InvestingPro data and tips offer additional context for investors. With a market capitalization of $100.3 billion and a Price to Earnings (P/E) ratio of 26.75, the company stands out as a significant entity in the insurance sector. Notably, its Price to Book ratio of 8.2 and revenue growth of 9.73% over the last twelve months as of Q1 2023 underscore the company's financial health and market valuation.

InvestingPro Tips highlight Marsh & McLennan's impressive track record of raising its dividend for 14 consecutive years and maintaining dividend payments for 54 consecutive years, signaling a strong commitment to shareholder returns. Additionally, the company's robust performance is reflected in its profitability over the last twelve months and a high return over the last decade. These factors, combined with the fact that analysts predict the company will remain profitable this year, provide a reassuring picture for potential and current investors.

For those seeking deeper insights, InvestingPro offers a wealth of additional tips for Marsh & McLennan, which can be accessed through a subscription. To enhance your investment analysis, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With 9 more InvestingPro Tips available, investors can gain a comprehensive understanding of the company's prospects and position in the industry.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.